top of page
Search


Control Bionics Expands Speech-Generating Devices in the United States
archTIS Limited (ASX: AR9) operates in a specialised segment of the cybersecurity market focused on data-centric security for government, defence, and regulated industries. The Company’s positioning within Zero Trust architecture and attribute-based access control (ABAC) environments places it in a sector where procurement cycles are long and compliance standards are strict.

Noel Ong
Mar 67 min read


Control Bionics Limited — U.S. Pilot Distribution Agreement with Tobii Dynavox
Control Bionics Limited (ASX: CBL) has announced a new agreement with Tobii Dynavox, a global leader in Augmentative and Alternative Communication (AAC), to evaluate a potential U.S. distribution partnership for its NeuroNode® technology. The agreement initiates a six-month pilot program across five north-western U.S. states, positioning NeuroNode alongside Tobii Dynavox’s established communication aids.

Noel Ong
Feb 135 min read
bottom of page
